SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-011813
Filing Date
2020-10-27
Accepted
2020-10-27 17:19:16
Documents
59
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20200930x10q.htm   iXBRL 10-Q 2034546
2 EX-10.1 qure-20200930xex10d1.htm EX-10.1 76776
3 EX-10.2 qure-20200930xex10d2.htm EX-10.2 65673
4 EX-10.3 qure-20200930xex10d3.htm EX-10.3 301084
5 EX-31.1 qure-20200930xex31d1.htm EX-31.1 14578
6 EX-31.2 qure-20200930xex31d2.htm EX-31.2 14574
7 EX-32.1 qure-20200930xex32d1.htm EX-32.1 8897
  Complete submission text file 0001558370-20-011813.txt   7841205

Data Files

Seq Description Document Type Size
8 EX-101.SCH qure-20200930.xsd EX-101.SCH 46310
9 EX-101.CAL qure-20200930_cal.xml EX-101.CAL 47103
10 EX-101.DEF qure-20200930_def.xml EX-101.DEF 222195
11 EX-101.LAB qure-20200930_lab.xml EX-101.LAB 471207
12 EX-101.PRE qure-20200930_pre.xml EX-101.PRE 358571
13 EXTRACTED XBRL INSTANCE DOCUMENT qure-20200930x10q_htm.xml XML 1246349
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 201265043
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences